Literature DB >> 12794202

Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa.

W Lai1, C Y Chen, S A Morse, Ye Htun, H G Fehler, H Liu, R C Ballard.   

Abstract

OBJECTIVES: To determine the aetiology of genital ulcer disease (GUD) and its association with HIV infection in the mining community of Carletonville, South Africa, from two cross sectional surveys of consecutive men presenting with genital lesions during October 1993 to January 1994 and July to November 1998.
METHODS: A multiplex polymerase chain reaction (M-PCR) assay combined with amplicon detection was used to identify DNA specific sequences of Treponema pallidum, herpes simplex virus (HSV), and Haemophilus ducreyi. A real time PCR assay was used to differentiate between HSV-1 and HSV-2.
RESULTS: M-PCR detected T pallidum, HSV, and H ducreyi in 10.3%, 17.2%, and 69.4% of 232 GUD patients during 1993-4 and in 12.4%, 36.0%, and 50.5% of 186 GUD patients in 1998. The proportion of patients with more than one agent increased significantly from 7.3% (17/232) in 1993-4 to 16.7% (31/186) in 1998 (p <0.01). HSV-2 was detected in a higher proportion of ulcer specimens from HIV infected patients than in specimens from HIV uninfected patients during both time periods (1993-4: 26.2% v 6.7%, p <0.001; 1998: 42.1% v 29.6%, p >0.09).
CONCLUSIONS: Based on two cross sectional surveys, 4 years apart, chancroid remained the leading cause of GUD in men who presented at the STD clinic with genital ulcers in the mining community of Carletonville, South Africa. The relative prevalence of primary syphilis has remained low. However, HSV-2 has emerged as a more significant cause of GUD and the proportion of GUD patients infected with more than one agent also increased significantly. HSV-2 DNA was detected in a significantly higher proportion of ulcer specimens from HIV positive patients than from HIV negative patients. No association was found between HIV infection status and the relative prevalence of chancroid or syphilis.

Entities:  

Mesh:

Year:  2003        PMID: 12794202      PMCID: PMC1744684          DOI: 10.1136/sti.79.3.202

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  33 in total

Review 1.  Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes.

Authors:  N O'Farrell
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

2.  Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection.

Authors:  C Y Chen; R C Ballard; C M Beck-Sague; Y Dangor; F Radebe; S Schmid; J B Weiss; V Tshabalala; G Fehler; Y Htun; S A Morse
Journal:  Sex Transm Dis       Date:  2000-01       Impact factor: 2.830

3.  Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.

Authors:  S D Holmberg; J A Stewart; A R Gerber; R H Byers; F K Lee; P M O'Malley; A J Nahmias
Journal:  JAMA       Date:  1988-02-19       Impact factor: 56.272

Review 4.  Targeted interventions required against genital ulcers in African countries worst affected by HIV infection.

Authors:  N O'Farrell
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

5.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Authors:  Anna Wald; Katherine Link
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

6.  Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; F J Rixon
Journal:  J Mol Biol       Date:  1985-01-05       Impact factor: 5.469

7.  Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands.

Authors:  S M Bruisten; I Cairo; H Fennema; A Pijl; M Buimer; P G Peerbooms; E Van Dyck ; A Meijer; J M Ossewaarde; G J van Doornum
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

8.  DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons.

Authors:  D J McGeoch; H W Moss; D McNab; M C Frame
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

9.  Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi.

Authors:  J R Dyer; J J Eron; I F Hoffman; P Kazembe; P L Vernazza; E Nkata; C Costello Daly; S A Fiscus; M S Cohen
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

10.  Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania.

Authors:  María del Mar Pujades Rodríguez; Angela Obasi; Frank Mosha; Jim Todd; David Brown; John Changalucha; David Mabey; David Ross; Heiner Grosskurth; Richard Hayes
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

View more
  16 in total

1.  Aetiology of sexually transmitted infections and response to syndromic treatment in southwest Uganda.

Authors:  J M Pickering; J A G Whitworth; P Hughes; M Kasse; D Morgan; B Mayanja; L Van der Paal; P Mayaud
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

2.  Evidence for differences in immunologic and pathogenesis properties of herpes simplex virus 2 strains from the United States and South Africa.

Authors:  Timothy E Dudek; Ernesto Torres-Lopez; Clyde Crumpacker; David M Knipe
Journal:  J Infect Dis       Date:  2011-04-14       Impact factor: 5.226

3.  Genomic sequences of a low passage herpes simplex virus 2 clinical isolate and its plaque-purified derivative strain.

Authors:  Robert Colgrove; Fernando Diaz; Ruchi Newman; Sakina Saif; Terry Shea; Sarah Young; Matt Henn; David M Knipe
Journal:  Virology       Date:  2013-12-31       Impact factor: 3.616

4.  Correlates of Bacterial Ulcers and Acute HSV-2 Infection among Men with Genital Ulcer Disease in South Africa: Age, Recent Sexual Behaviors, and HIV.

Authors:  Jami S Leichliter; David A Lewis; Gabriela Paz-Bailey
Journal:  S Afr J Infect Dis       Date:  2016-01-25

5.  Comparative Analysis of UL16 Mutants Derived from Multiple Strains of Herpes Simplex Virus 2 (HSV-2) and HSV-1 Reveals Species-Specific Requirements for the UL16 Protein.

Authors:  Jie Gao; Xiaohu Yan; Bruce W Banfield
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

6.  Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.

Authors:  Fernando Diaz; Sean Gregory; Hiroshi Nakashima; Mariano S Viapiano; David M Knipe
Journal:  Virology       Date:  2017-10-22       Impact factor: 3.616

7.  Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections.

Authors:  Miguel A Minaya; Travis L Jensen; Johannes B Goll; Maria Korom; Sree H Datla; Robert B Belshe; Lynda A Morrison
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 8.  Sentinel surveillance of sexually transmitted infections in South Africa: a review.

Authors:  L F Johnson; D J Coetzee; R E Dorrington
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

Review 9.  Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Authors:  Jairam R Lingappa; Connie Celum
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda.

Authors:  T R Suntoke; A Hardick; A A R Tobian; B Mpoza; O Laeyendecker; D Serwadda; P Opendi; C A Gaydos; R H Gray; M J Wawer; T C Quinn; S J Reynolds
Journal:  Sex Transm Infect       Date:  2008-12-09       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.